Patient Guide: Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 198 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04915755
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Neoplasms, Triple Negative Breast Neoplasms
Phase: PHASE3

Find a Study Location Near You

This study is available at 198 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Burbank, California
  • Duarte, California
  • Palo Alto, California
  • • And 195 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily